Kuano, a Cambridge-based drug discovery company combining quantum mechanics with AI to design the next generation of medicines, has closed a £1.8m seed funding round led by Mercia Ventures and including ACF Investors, Ascension Ventures, o2h Ventures, Meltwind Advisory LLP and other angel investors.